Oral formulations of MS drugs said to be effective

Friday 22 January 2010

Oral formulations of two investigational drugs for multiple sclerosis have been shown to be effective in reducing the rate of disease relapse, according to three papers in the New England Journal of Medicine. The drugs are oral fingolimod and oral cladribine.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland

See map: Google Maps